Valeant’s $10bn bond largest pharma deal
Valeant Pharmaceuticals International, the Canadian drugs company, sold the largest syndicated high yield bond in the healthcare sector on record, according to Dealogic, and also the largest Canadian syndicated high yield bond on record across all sectors.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts